◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

BioRem Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 37.4M 25.2M 28.9M 24.5M
Operating Revenue 37.4M 25.2M 28.9M 24.5M
Cost Of Revenue 27.4M 18.1M 20.1M 18.2M
Gross Profit 10.1M 7.0M 8.8M 6.2M
Selling General And Administration 5.6M 3.9M 5.8M 3.9M
General And Administrative Expense 2.1M 1.6M 3.2M 1.8M
Research And Development 43,859 30,440 97,123 14,223
Other Operating Expenses -- 23,516 238,116 -25,000
Operating Expense 5.7M 3.9M 6.1M 3.9M
Operating Income 4.4M 3.1M 2.6M 2.3M
EBIT 4.3M 3.1M 2.6M 2.1M
Interest Expense 195,476 273,435 257,179 35,860
Interest Expense Non Operating 195,476 273,435 257,179 35,860
Net Interest Income -195,476 -273,435 -257,179 -35,860
Other Income Expense -49,793 -23,516 -238,116 -263,677
Gain On Sale Of Security -49,793 -23,516 -238,116 -263,677
Pretax Income 4.1M 2.8M 2.4M 2.0M
Tax Provision 1.1M 609,741 770,351 736,991
Tax Effect Of Unusual Items -13,260 -5,141 0.00 -95,524
Net Income From Continuing And Discontinued Operation 3.0M 2.2M 1.6M 1.3M
Net Income From Continuing Operation Net Minority Interest 3.0M 2.2M 1.6M 1.3M
Net Income Including Noncontrolling Interests 3.0M 2.2M 1.6M 1.3M
Net Income Common Stockholders 3.0M 2.2M 1.6M 1.3M
Net Income 3.0M 2.2M 1.6M 1.3M
EBITDA 4.8M 3.4M 3.0M 2.4M
Normalized EBITDA 4.9M 3.5M 3.0M 2.7M
Reconciled Depreciation 473,126 382,706 350,648 343,624
Basic EPS 0.19 0.14 0.10 0.04
Diluted EPS 0.16 0.13 0.09 0.04
Basic Average Shares 15.8M 15.7M 15.5M 35.9M
Diluted Average Shares 18.7M 17.1M 17.6M 37.4M
Total Unusual Items -49,793 -23,516 -238,116 -263,677
Total Unusual Items Excluding Goodwill -49,793 -23,516 -238,116 -263,677
Tax Rate For Calcs 0.27 0.22 0.32 0.36
Normalized Income 3.1M 2.2M 1.6M 1.5M
Diluted NI Availto Com Stockholders 3.0M 2.2M 1.6M 1.3M
Net Income Continuous Operations 3.0M 2.2M 1.6M 1.3M
Net Non Operating Interest Income Expense -195,476 -273,435 -257,179 -35,860
Other Gand A 2.1M 1.6M 3.2M 1.8M
Reconciled Cost Of Revenue 27.4M 18.1M 20.1M 18.2M
Selling And Marketing Expense 3.5M 2.3M 2.6M 2.1M
Total Expenses 33.0M 22.1M 26.2M 22.1M
Total Operating Income As Reported 4.3M 3.1M 2.6M 2.1M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 5.2M 2.3M 3.8M 4.5M
Cash Cash Equivalents And Short Term Investments 5.2M 2.3M 3.8M 4.5M
Cash Financial 5.2M 2.3M 3.8M 4.5M
Accounts Receivable 11.9M 11.1M 8.4M 6.5M
Receivables 14.9M 14.1M 12.2M 10.1M
Inventory 2.9M 901,139 888,045 901,670
Prepaid Assets 1.5M 2.3M 870,618 658,884
Current Assets 24.5M 19.6M 17.8M 16.2M
Gross PPE 5.9M 5.8M 5.2M 4.9M
Accumulated Depreciation -3.9M -3.8M -4.1M -3.7M
Net PPE 2.0M 2.0M 1.0M 1.1M
Total Non Current Assets 4.0M 4.4M 3.0M 3.0M
Total Assets 28.5M 24.1M 20.7M 19.2M
Current Debt 570,512 547,478 1.3M 1.5M
Current Debt And Capital Lease Obligation 690,073 723,163 1.5M 1.7M
Accounts Payable 4.0M 6.1M 4.7M 5.1M
Payables 5.0M 6.3M 5.6M 5.5M
Payables And Accrued Expenses 7.4M 8.4M 8.3M 8.0M
Current Accrued Expenses 2.4M 2.1M 2.7M 2.5M
Current Deferred Revenue 6.4M 4.3M 2.6M 3.0M
Current Liabilities 15.0M 13.9M 12.9M 13.2M
Long Term Debt 1.9M 2.4M 3.0M 3.5M
Long Term Debt And Capital Lease Obligation 2.9M 3.5M 3.3M 4.0M
Long Term Capital Lease Obligation 1.0M 1.0M 312,439 469,916
Total Non Current Liabilities Net Minority Interest 2.9M 3.5M 3.3M 4.0M
Total Liabilities Net Minority Interest 17.9M 17.4M 16.2M 17.2M
Common Stock 5.2M 5.0M 4.9M 4.9M
Capital Stock 5.2M 5.0M 4.9M 4.9M
Additional Paid In Capital 2.5M 2.4M 2.3M 2.2M
Retained Earnings 1.1M -1.9M -4.1M -5.7M
Gains Losses Not Affecting Retained Earnings 1.8M 1.3M 1.4M 597,343
Other Equity Adjustments 1.8M 1.3M 1.4M 597,343
Common Stock Equity 10.6M 6.7M 4.5M 2.0M
Stockholders Equity 10.6M 6.7M 4.5M 2.0M
Total Equity Gross Minority Interest 10.6M 6.7M 4.5M 2.0M
Total Capitalization 12.5M 9.1M 7.5M 5.5M
Net Tangible Assets 10.6M 6.7M 4.5M 2.0M
Tangible Book Value 10.6M 6.7M 4.5M 2.0M
Working Capital 9.5M 5.7M 4.9M 2.9M
Invested Capital 13.1M 9.7M 8.8M 7.0M
Total Debt 3.6M 4.2M 4.7M 5.7M
Net Debt -- 684,338 501,223 538,696
Share Issued 16.1M 15.7M 15.5M 15.5M
Ordinary Shares Number 16.1M 15.7M 15.5M 15.5M
Allowance For Doubtful Accounts Receivable -- -- -- -1.0M
Capital Lease Obligations 1.1M 1.2M 469,915 655,603
Current Capital Lease Obligation 119,561 175,685 157,476 185,687
Current Deferred Liabilities 6.4M 4.3M 2.6M 3.0M
Current Provisions 538,367 425,758 621,988 490,225
Finished Goods 2.6M 847,072 719,279 730,104
Gross Accounts Receivable -- -- -- 7.6M
Income Tax Payable 959,573 169,806 893,426 445,831
Leases 889,894 882,141 903,279 886,247
Line Of Credit -- -- -- 1.0M
Machinery Furniture Equipment 902,180 990,212 899,824 695,684
Non Current Accounts Receivable 811,293 971,659 -- --
Non Current Deferred Assets 1.2M 1.5M 1.9M 1.9M
Non Current Deferred Taxes Assets 1.2M 1.5M 1.9M 1.9M
Other Current Borrowings 570,512 547,478 1.3M 1.5M
Other Properties 4.1M 3.9M 3.4M 3.3M
Other Receivables 3.0M 3.0M 3.9M 3.6M
Properties 0.00 0.00 0.00 0.00
Raw Materials 304,453 54,067 168,766 171,566
Total Tax Payable 959,573 169,806 893,426 445,831
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow 3.7M 490,033 1.4M 3.8M
Cash Flow From Continuing Operating Activities 3.7M 490,033 1.4M 3.8M
Depreciation And Amortization 473,126 382,706 350,648 343,624
Depreciation Amortization Depletion 473,126 382,706 350,648 343,624
Stock Based Compensation 143,070 127,650 93,693 8,439
Deferred Tax 383,439 458,661 83,655 381,922
Deferred Income Tax 383,439 458,661 83,655 381,922
Change In Working Capital -441,498 -2.7M -735,754 1.7M
Changes In Account Receivables 44,259 -4.0M -1.3M -185,626
Change In Receivables 239,457 -3.0M -1.7M -2.5M
Change In Inventory -1.8M -39,022 245,499 43,110
Change In Payables And Accrued Expense -1.5M 214,811 1.1M 3.9M
Change In Payable -1.8M 676,404 1.1M 3.6M
Change In Other Working Capital 1.8M 1.6M -277,045 162,711
Other Non Cash Items 83,226 84,127 39,615 50,541
Capital Expenditure -372,001 -552,872 -203,289 -75,979
Purchase Of PPE -372,001 -552,872 -203,289 -75,979
Net PPE Purchase And Sale -372,001 -552,872 -203,289 -75,979
Investing Cash Flow -372,001 -552,872 -203,289 -75,979
Cash Flow From Continuing Investing Activities -372,001 -552,872 -203,289 -75,979
Issuance Of Debt -- -- -- 5.0M
Repayment Of Debt -728,940 -1.4M -953,798 -239,125
Net Issuance Payments Of Debt -728,940 -1.4M -953,798 4.8M
Issuance Of Capital Stock 156,900 69,000 2,000 --
Repurchase Of Capital Stock -- -- 0.00 -12.4M
Net Common Stock Issuance 156,900 69,000 2,000 -12.4M
Common Stock Payments -- -- 0.00 -12.4M
Financing Cash Flow -572,040 -1.3M -951,798 -7.6M
Cash Flow From Continuing Financing Activities -572,040 -1.3M -951,798 -7.6M
Effect Of Exchange Rate Changes 179,998 -91,149 -986,113 -548,247
Changes In Cash 2.7M -1.4M 289,827 -3.8M
Beginning Cash Position 2.3M 3.8M 4.5M 8.9M
End Cash Position 5.2M 2.3M 3.8M 4.5M
Free Cash Flow 3.3M -62,839 1.2M 3.7M
Change In Account Payable -2.5M 1.4M 743,500 3.3M
Change In Accrued Expense 232,574 -461,593 57,027 320,748
Change In Income Tax Payable 750,658 -704,404 348,203 304,250
Change In Prepaid Assets 835,072 -1.4M -130,226 145,267
Change In Tax Payable 750,658 -704,404 348,203 304,250
Common Stock Issuance 156,900 69,000 2,000 --
Depreciation 473,126 382,706 350,648 343,624
Long Term Debt Issuance -- -- -- 5.0M
Long Term Debt Payments -728,940 -1.4M -718,799 -239,125
Net Income From Continuing Operations 3.0M 2.2M 1.6M 1.3M
Net Long Term Debt Issuance -728,940 -1.4M -718,799 4.8M
Net Short Term Debt Issuance -- -775,001 -234,999 --
Proceeds From Stock Option Exercised -- -- 2,000 84,575
Short Term Debt Payments -- -775,001 -234,999 --
NEWS
Loading news...
TRENDING
Loading...